南京通享科技有限公司旗下网站 南京通享科技有限公司旗下网站    QQ 客服QQ:848993746   QQ 客服短信:18913948480   QQ 常见问题解答  UNSV.COM淘宝店铺 UNSV.COM淘宝店铺 QQ 收藏网站   QQ 默认主页  
<编辑> <发布> <推荐给好友> <收藏此文章> <适合打印版式> <上篇文章> <下篇文章>

DEVELOPMENT REPORT - New Cervical Cancer Test for Developing Countries

VOA Special English配套节目资料下载  配套节目资料下载 VOA Special English配套节目资料下载常见问题解答 下载常见问题解答
节目资料名称下载位置
pdf.gif PDF 广播稿下载 (22 K) 中国电信·南京
mp3.gif MP3 声音下载 (915 K) 中国电信·南京
下载提示:请用右键点下载链接,在弹出菜单上选“目标另存为...”。
LRC 歌词下载请用左键点击。仅限实名、高级会员使用。

This is Robert Cohen with the VOA Special English Development Report.

Researchers say more than two-hundred-thousand women a year die from cervical cancer. These deaths are most common in developing countries.

The main cause of cervical cancer is the human papillomavirus, or H-P-V. This is a common virus that men or women can give each other through sex. H-P-V may go away. But if it remains in the body, it greatly increases the chances of cervical cancer.

The cervix is part of the female reproductive system. It is the opening at the end of the uterus.

Cervical cancers develop slowly, usually over a period of ten or twenty years. There are tests that can find the disease early enough to save a woman's life. A common test is called a Pap smear. Laboratory workers examine cells under a microscope.

But many national health systems do not have money for these tests. In other cases, there might be cultural issues. As a result, more than eighty percent of women who die from cervical cancer are in poor nations.

Graphic Image
Graphic Image

Now a company in the United States says it plans to create a new test for cervical cancer in developing countries. The biotechnology company Digene says it expects research and development to take up to five years.

The test will be based on Digene technology already approved for use in laboratories in the United States and Europe. This technology uses computers to examine the genetic material in cells.

The goal is a test that is fast and low cost, has ease of use and is culturally acceptable. Women themselves might even be able to collect the cells during their visit to a doctor. The company says the aim is to collect cells and get the test results during the same visit. If pre-cancerous cells are found, health workers may then freeze them to kill them. If cancer is found, doctors may order radiation or other treatments.

Digene notes that cervical cancer is now considered one of the most preventable cancers in rich nations. But it is a leading cause of cancer deaths among women in South and Central America, Africa and Southeast Asia.

A non-profit group in Seattle, Washington, called PATH will give more than two-million dollars to the Digene project. PATH is Program for Appropriate Technology in Health. The money is from a program paid for by a thirteen-million dollar gift from the Bill and Melinda Gates Foundation.

This VOA Special English Development Report was written by Jill Moss. This is Robert Cohen.

Windows Live Messenger MSN/Email: webmaster@unsv.com  人人网空间 人人网空间    QQ QQ空间: http://848993746.qzone.qq.com    淘宝旺旺 淘宝旺旺ID: myunsv
版权所有©2003-2010 南京通享科技有限公司,保留所有权利。 苏ICP证:苏B2-20070025